Towards MRI guided radiotherapy of renal cell carcinoma

Towards MRI guided radiotherapy of renal cell carcinoma - MRI-RCC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42445

Enrollment

Registered

2015-10-05

Start date

2015-12-17

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney cancer Renal cell carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with a solid lesion suspect for RCC or a cystic lesion Bosniak classification > IIF; - * 18 years; - Written informed consent.

Exclusion criteria

Exclusion criteria: - Fulfilling one of the exclusion criteria for MRI at 1.5T/3T according to the protocol of the department of Radiology, UMC Utrecht; - Fulfilling the exclusion criteria for the Gadovist gadolinium (glomerular filtration rate (GFR) of

Design outcomes

Primary

Measure	Time frame
To make MRI suitable for MR-guided (MR-linac) stereotactic radiotherapy for localized RCC. The current predicate MRI work includes MRI-sequence optimisation (to allow for MR-based delineation) and MR-guidance during treatment.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results